Vasella’s $78 Million Novartis Payout Boosts ‘Fat-Cat’ Crackdown

Novartis AG’s 72 million Swiss-franc ($78 million) payout to prevent outgoing chairman Daniel Vasella from working for a rival undermines the cause of campaigners fighting to avoid tougher curbs on executive pay in Switzerland.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.